Markets:

Overview

News

Currencies

International

Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

86.38 -3.89 (-4.31%)

Streaming Delayed Price Updated: 3:03 PM EDT, Jul 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Twist Bioscience Launches Enzymatic Fragmentation Library Preparation Kit for High Uniformity, High-Yield Amplification, Streamlined Next Generation Sequencing Workflow for Targeted Applications

May 25, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Present at Upcoming Virtual Conferences

May 25, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Supports the Engineering Biology Research Consortium as it Publishes Statement of Ethics

May 13, 2021

From Twist Bioscience Corporation

Via Business Wire

Earnings Scheduled For May 6, 2021 ↗

May 06, 2021

Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion. • Cohen...

Via Benzinga

64 Biggest Movers From Yesterday ↗

May 11, 2021

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 82.6% to settle at $6.39 on Monday. Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares surged 53.5% to close at $3....

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 10, 2021

Gainers Protagenic Therapeutics (NASDAQ:PTIX) shares increased by 84.03% to $3.92 during Monday's regular session. Trading volume for this security as of 12:30 EST is...

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

Barron's Picks And Pans: Hannon Armstrong, Seagate, Tesla, Virtu Financial And More ↗

May 09, 2021

This weekend's Barron's cover story helps investors to prepare for the changes ahead. Other featured articles discuss how to invest in tomorrow's big tech trends,...

Via Benzinga

What Are the Risks With Twist Bioscience? ↗

May 08, 2021

One especially stands out.

Via The Motley Fool

Twist Bioscience Corp (TWST) Q2 2021 Earnings Call Transcript ↗

May 07, 2021

TWST earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Twist Bioscience Reports Second Quarter Fiscal 2021 Financial Results

May 06, 2021

From Twist Bioscience Corporation

Via Business Wire

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Why Does Cathie Wood Like This Healthcare Stock So Much? ↗

May 06, 2021

Twist Bioscience brings to mind another genomic revolution pioneer.

Via The Motley Fool

3 Exciting Biotech Stocks to Buy Right Now ↗

April 30, 2021

Gene therapies could be poised to enter an era of extraordinarily rapid advancement.

Via The Motley Fool

Twist Bioscience and Vivlion Partner to Generate gRNA Libraries for CRISPR Applications

April 28, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Report Fiscal 2021 Second Quarter Financial Results on Thursday, May 6, 2021

April 22, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Expand Oregon Lease, Supporting Future Growth

April 16, 2021

From Twist Bioscience Corporation

Via Business Wire

Pure Biologics Selects Twist Bioscience to Expand Phage Display Technology Capabilities

April 14, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Exercises Option to Purchase Custom Designed Antibody Library and Optimization Software

April 12, 2021

From Twist Bioscience

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2021 ↗

April 12, 2021

Upgrades For Eni SpA (NYSE:E), Credit Suisse upgraded the previous rating of Underperform to Neutral. For the fourth quarter, Eni had an EPS of $0.02, compared to year-ago...

Via Benzinga

Ginkgo Bioworks, Which Prints DNA And Creates Genetically Modified Food, Exploring SPAC Deal: Report ↗

April 09, 2021

One of the largest SPACs seeking a target could be nearing a $20 billion deal to bring one of the largest privately-held biotechnology companies public. The SPAC Rumor: Bloomberg...

Via Benzinga

AcornMed Selects Twist Bioscience Technology to Power Next Generation Precision Medicine Tests

April 07, 2021

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Provide Antibody Discovery, Optimization and Access to Library of Libraries for Drug Research to Stanford University Laboratories

April 07, 2021

From Twist Bioscience Corporation

Via Business Wire

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.